Compile Data Set for Download or QSAR
Report error Found 48 Enz. Inhib. hit(s) with all data for entry = 10489
TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540695BDBM540695(3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  3nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540719BDBM540719((E)-3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  3nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540694BDBM540694(3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540693BDBM540693(3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540732BDBM540732(US11261190, Example 60B)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540700BDBM540700(US11261190, Example 24)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540689BDBM540689(3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540707BDBM540707((R)-methyl 6-(((S)-2-(4-acetylphenyl)-3-oxohexahyd...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540712BDBM540712(3-(3-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540696BDBM540696(3-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540698BDBM540698(US11261190, Example 22)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540733BDBM540733(US11261190, Example 61B)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540701BDBM540701(US11261190, Example 25)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540704BDBM540704(US11261190, Example 28)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540691BDBM540691(2-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540705BDBM540705(US11261190, Example 29)
Affinity DataEC50:  6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540708BDBM540708(US11261190, Example 32)
Affinity DataEC50:  6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540699BDBM540699(US11261190, Example 23)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540703BDBM540703(US11261190, Example 27)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540690BDBM540690(2-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540711BDBM540711(US11261190, Example 35)
Affinity DataEC50:  8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540702BDBM540702(US11261190, Example 26)
Affinity DataEC50:  8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540717BDBM540717(US11261190, Example 45)
Affinity DataEC50:  8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540722BDBM540722(US11261190, Example 50B)
Affinity DataEC50:  8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540727BDBM540727(US11261190, Example 55)
Affinity DataEC50:  9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540723BDBM540723(US11261190, Example 51B)
Affinity DataEC50:  9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540716BDBM540716(US11261190, Example 44)
Affinity DataEC50:  10nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540720BDBM540720(US11261190, Example 48)
Affinity DataEC50:  10nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540726BDBM540726((E)-3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  11nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540728BDBM540728(US11261190, Example 56)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540729BDBM540729(US11261190, Example 57)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540706BDBM540706(US11261190, Example 30)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540721BDBM540721((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540724BDBM540724((E)-3-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  13nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540725BDBM540725((E)-3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540730BDBM540730(US11261190, Example 58B)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540692BDBM540692(US11261190, Example 16)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540713BDBM540713(US11261190, Example 38)
Affinity DataEC50:  15nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540731BDBM540731(US11261190, Example 59B)
Affinity DataEC50:  15nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540710BDBM540710(US11261190, Example 34)
Affinity DataEC50:  16nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540697BDBM540697(2-(4-(((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(...)
Affinity DataEC50:  22nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540718BDBM540718(2-((tert-butoxycarbonyl)amino)-2-(4-((S)-7-(((R)-6...)
Affinity DataEC50:  22nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540709BDBM540709(US11261190, Example 33)
Affinity DataEC50:  25nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540714BDBM540714(US11261190, Example 39)
Affinity DataEC50:  29nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540687BDBM540687((2R)-2-(7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(met...)
Affinity DataEC50:  32nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540688BDBM540688(3-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(meth...)
Affinity DataEC50:  37nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540686BDBM540686((2R,4S)-4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)...)
Affinity DataEC50:  56nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent

TargetLarge envelope protein(HBV-D)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 540715BDBM540715(2-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  71nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
US Patent